Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
1.
Cancer Radiother ; 26(6-7): 779-783, 2022 Oct.
Artículo en Francés | MEDLINE | ID: mdl-36030190

RESUMEN

Stereotactic radiotherapy and radiosurgery allow delivery of high irradiation doses in a limited volume. These techniques are specially adapted to brain and nervous pathologies. Indication are not only cancers and tumors but also non tumor tissues such as arteriovenous malformations. In some case purpose of stereotactic radiotherapy is solely functional, for example for trigeminal neuralgia. We detail the questions that raise treatment of these non-tumor pathologies. These pathologies imply a multidisciplinary approach that associate radiation oncologists, neuro-radiologist and neurosurgeons.


Asunto(s)
Malformaciones Arteriovenosas , Neoplasias , Radiocirugia , Neuralgia del Trigémino , Encéfalo , Humanos , Radiocirugia/métodos , Neuralgia del Trigémino/radioterapia
2.
Radiat Oncol ; 10: 170, 2015 Aug 14.
Artículo en Inglés | MEDLINE | ID: mdl-26268888

RESUMEN

PURPOSE/OBJECTIVES: To assess feasibility and toxicity of Helical TomoTherapy for treating anal cancer patients. METHODS: From 2007 to 2011, 64 patients were consecutively treated with TomoTherapy in three centres for locally advanced squamous-cell anal carcinoma (T2 > 4 cm or N positive). Prescribed doses were 45 Gy to the pelvis including inguinal nodes and 59.4 Gy to the primary site and involved nodes with fractions of 1.8 Gy, five days a week. A positional Megavoltage Computed Tomography was performed before each treatment session. All acute and late toxicities were graded according to Common Terminology Criteria for Adverse Events version 3.0. Survival analysis was performed using the Kaplan-Meier method. RESULTS: Median follow-up was 22.9 months. Fifty-four women and 10 men were treated (median age: 62 years). Nineteen patients (29.7%) had T2, 16 patients (25.0%) T3, and 27 patients (42.2%) T4 tumours. Thirty-nine patients (60.9%) had nodal involvement. Median tumour size was 45 mm (range, 10-110 mm). Seven patients had a colostomy before treatment initiation. Fifty-seven patients received concomitant chemotherapy (5-FU/cisplatin or 5-FU/mitomycin-based therapy). Forty-seven patients (73.4 %) experienced a complete response, 13 a partial response or local recurrence, and 11 had salvage surgery; among these, six became complete responders, three experienced metastatic failure, and two local failure. At least four patients experienced metastatic recurrence (concomitant to a local failure for one patient). The two-year overall survival was 85.6% (95 %CI [71.1%-93.0%]), and the one-year disease-free survival, and colostomy-free survival were 68.7% (95 %CI [54.4%-79.4]), and 75.5% (95 %CI [60.7%-85.3%]) respectively. Overall survival, disease-free survival and colostomy free-survival were significantly better for women than men (p = 0.002, p = 0.004, and p = 0.002 respectively). Acute grade ≥3 toxicity included dermatologic (46.9% of patients), gastrointestinal (20.3%), and hematologic (17.2%) toxicity. Acute grade 4 hematologic toxicity occurred in one patient. No grade 5 event was observed. CONCLUSIONS: TomoTherapy for locally advanced anal cancer is feasible. In our three centres of expertise, this technique appeared to produce few acute gastrointestinal toxicities. However, high rates of dermatologic toxicity were observed. The therapeutic efficacy was within the range of expectations and similar to previous studies in accordance with the high rates of locally advanced tumours and nodal involvement.


Asunto(s)
Neoplasias del Ano/radioterapia , Carcinoma de Células Escamosas/radioterapia , Radioterapia de Intensidad Modulada/métodos , Adulto , Anciano , Anciano de 80 o más Años , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Neoplasias del Ano/tratamiento farmacológico , Neoplasias del Ano/mortalidad , Carcinoma de Células Escamosas/tratamiento farmacológico , Carcinoma de Células Escamosas/mortalidad , Quimioradioterapia/efectos adversos , Quimioradioterapia/métodos , Cisplatino/administración & dosificación , Supervivencia sin Enfermedad , Femenino , Fluorouracilo/administración & dosificación , Francia , Humanos , Estimación de Kaplan-Meier , Masculino , Persona de Mediana Edad , Dosis de Radiación , Radioterapia de Intensidad Modulada/efectos adversos
3.
Strahlenther Onkol ; 191(3): 217-24, 2015 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-25245468

RESUMEN

BACKGROUND AND PURPOSE: Positron emission tomography (PET) with [(18)F]-fluoromisonidazole ([(18)F]-FMISO) provides a non-invasive assessment of hypoxia. The aim of this study is to assess the feasibility of a dose escalation with volumetric modulated arc therapy (VMAT) guided by [(18)F]-FMISO-PET for head-and-neck cancers (HNC). PATIENTS AND METHODS: Ten patients with inoperable stages III-IV HNC underwent [(18)F]-FMISO-PET before radiotherapy. Hypoxic target volumes (HTV) were segmented automatically by using the fuzzy locally adaptive Bayesian method. Retrospectively, two VMAT plans were generated delivering 70 Gy to the gross tumour volume (GTV) defined on computed tomography simulation or 79.8 Gy to the HTV. A dosimetric comparison was performed, based on calculations of tumour control probability (TCP), normal tissue complication probability (NTCP) for the parotid glands and uncomplicated tumour control probability (UTCP). RESULTS: The mean hypoxic fraction, defined as the ratio between the HTV and the GTV, was 0.18. The mean average dose for both parotids was 22.7 Gy and 25.5 Gy without and with dose escalation respectively. FMISO-guided dose escalation led to a mean increase of TCP, NTCP for both parotids and UTCP by 18.1, 4.6 and 8% respectively. CONCLUSION: A dose escalation up to 79.8 Gy guided by [(18)F]-FMISO-PET with VMAT seems feasible with improvement of TCP and without excessive increase of NTCP for parotids.


Asunto(s)
Carcinoma de Células Escamosas/radioterapia , Hipoxia de la Célula/efectos de la radiación , Misonidazol/análogos & derivados , Neoplasias de Oído, Nariz y Garganta/radioterapia , Tomografía de Emisión de Positrones , Dosificación Radioterapéutica , Planificación de la Radioterapia Asistida por Computador/métodos , Radioterapia de Intensidad Modulada/métodos , Radioterapia/métodos , Anciano , Carcinoma de Células Escamosas/patología , Humanos , Masculino , Persona de Mediana Edad , Misonidazol/uso terapéutico , Estadificación de Neoplasias , Neoplasias de Oído, Nariz y Garganta/patología , Pronóstico , Carga Tumoral/efectos de la radiación
4.
Cell Motil Cytoskeleton ; 51(4): 169-76, 2002 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-11977091

RESUMEN

The presence of Myosin Va (an actin-based molecular motor) in the peripheral nervous system was examined and its subcellular distribution within the axons of the sciatic nerve was demonstrated via immunocytochemistry. Myosin Va (M-Va) in the nerve was detected by using SDS-PAGE and Western blot techniques with a polyclonal antibody specifically raised against the M-Va globular tail domain. In addition, purification of M-Va from the rat sciatic nerve prior to immunoblotting yielded a M-Va standard band. Likewise, optical immunocytochemical procedures revealed the presence of M-Va, particularly in the cortical axoplasmic territory, but also in the Schwann cell soma. The above experiments were carried out both on intact as well as on severed sciatic nerves with similar results. The proximal stumps of severed sciatic nerves (from 0 to 72 h after injury) were labelled in vivo with (35)S-methionine. SDS-PAGE autoradiography of the immunoabsorbed M-Va from the radiolabelled homogenized nerve tissue showed a significant increment of the radioactive intensity of M-Va heavy chain band through time. Moreover, a significant increment of transcripts coding for M-Va heavy chain was detected through time using RT-PCR after nerve injury and compared to intact nerves. This data suggest that M-Va is up-regulated in a time-dependent manner. The latter suggests a possible involvement of M-Va in nerve regeneration processes.


Asunto(s)
Actinas/fisiología , Miosina Tipo V/fisiología , Regeneración Nerviosa/fisiología , Nervio Ciático/lesiones , Actinas/biosíntesis , Animales , Axones/metabolismo , Western Blotting , Inmunohistoquímica , Miosina Tipo V/biosíntesis , Ratas , Ratas Wistar , Nervio Ciático/fisiología
5.
J Neurosci Res ; 62(6): 840-6, 2000 Dec 15.
Artículo en Inglés | MEDLINE | ID: mdl-11107169

RESUMEN

Synaptosomes from the optic lobes of squid (Loligo forbesi) were prepared by homogenization and allowed to settle onto glass coverslips. Synaptosomes were loaded with Ca(2+) sensitive dyes (Fura-2 AM, Calcium Green-1 AM and Calcium Green-5N AM), visualized by light microscopy and Ca(2+) sensitive fluorescence signals recorded and analyzed. With Fura-2, resting Ca(2+) was found to be 80 nM (n = 10, SEM 5.7). Addition of K(+) (30 mM), caffeine (3 mM) and thapsigargin (10 microM) evoked transient increases in cytoplasmic Ca(2+). Addition of BAPTA-AM (20 microM) decreased intrasynaptosomal free Ca(2+). Similar results were obtained with Calcium Green-1 AM but not with Calcium Green-5N AM. We conclude that synaptosomes from the squid optic lobe posses intact membranes and mechanisms to regulate intrasynaptosomal free [Ca(2+)], as well as caffeine sensitive Ca(2+) stores. The results of this study are discussed with respect to the role of Ca(2+) in presynaptic protein synthesis.


Asunto(s)
Calcio/metabolismo , Colorantes Fluorescentes/metabolismo , Lóbulo Óptico de Animales no Mamíferos/metabolismo , Sinaptosomas/metabolismo , Animales , Cafeína/farmacología , Estimulantes del Sistema Nervioso Central/farmacología , Quelantes/farmacología , Decapodiformes , Ácido Egtácico/análogos & derivados , Ácido Egtácico/farmacología , Inhibidores Enzimáticos/farmacología , Potenciales de la Membrana/efectos de los fármacos , Potenciales de la Membrana/fisiología , Lóbulo Óptico de Animales no Mamíferos/efectos de los fármacos , Compuestos Orgánicos , Cloruro de Potasio/farmacología , Sinaptosomas/efectos de los fármacos , Tapsigargina/farmacología
6.
J Neurosci Res ; 62(1): 65-74, 2000 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-11002288

RESUMEN

Local protein synthesis within axons has been studied on a limited scale. In the present study, several techniques were used to investigate this synthesis in sciatic nerve, and to show that it increases after damage to the axon. Neurofilament (NF) mRNAs were probed by RT-PCR, Northern blot and in situ hybridization in axons of intact rat sciatic nerve, and in proximal or distal stumps after sciatic nerve transection. RT-PCR demonstrated the presence of NF-L, NF-M and NF-H mRNAs in intact sciatic nerve, as well as in proximal and distal stumps of severed nerves. Northern blot analysis of severed nerve detected NF-L and NF-M, but not NF-H. This technique did not detect the three NFs mRNAs in intact nerve. Detection of NF-L and NF-M mRNA in injured nerve, however, indicated that there was an up-regulation in response to nerve injury. In situ hybridization showed that NF-L mRNA was localized in the Schwann cell perinuclear area, in the myelin sheath, and at the boundary between myelin sheath and cortical axoplasm. RNA and protein synthesizing activities were always greater in proximal as compared to distal stumps. NF triplet proteins were also shown to be synthesized de novo in the proximal stump. The detection of neurofilament mRNAs in nerves, their possible upregulation during injury and the synthesis of neurofilament protein triplet in the proximal stumps, suggest that these mRNAs may be involved in nerve regeneration, providing a novel point of view of this phenomenon.


Asunto(s)
Proteínas de Neurofilamentos/genética , Proteínas de Neurofilamentos/metabolismo , Biosíntesis de Proteínas/genética , ARN Mensajero/metabolismo , Nervio Ciático/metabolismo , Animales , Autorradiografía , Axotomía , Northern Blotting , Hibridación in Situ , Masculino , Ratas , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Proteínas Ribosómicas/metabolismo , Células de Schwann/citología , Células de Schwann/metabolismo , Nervio Ciático/cirugía , Regulación hacia Arriba
7.
Mol Cell Biochem ; 199(1-2): 7-14, 1999 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-10544946

RESUMEN

The ATP dependent Ca2+ uptake of platelet vesicles was inhibited by the two hydrophobic drugs trifluoperazine (TFP) and propranolol (PROP). Inhibition was significantly lowered when Pi was used instead of oxalate as a precipitant agent. When the ATPase ligands substrate (Mg2+ and Pi) were absent of the efflux medium, a slow release of Ca2+ which did not couple with ATP synthesis (passive Ca2+ efflux) was observed. Both, TFP and PROP enhanced the passive Ca2+ efflux. This enhanced efflux was partially inhibited only when Mg2+ and Pi were added together to the efflux reaction media, but it was not affected by spermidine, ruthenium red or thapsigargin (TG). The Ca2+ ionophores A23187 and ionomycin, also enhanced passive Ca2+ efflux. However, in this case, Ca2+ efflux was inhibited just by inclusion of Mg2+ to the medium. Ca2+ efflux promoted by Triton X-100 was not affected by either Mg2+ or Pi, included together or separately into the efflux medium. The ATP <==> Pi measured in the presence of Triton X-100 and millimolar Ca2+ concentrations was inhibited by both TFP and PROP, but not by Ca2+ ionophores up to 4 microM. The data suggest that the observed enhancement of passive Ca2+ efflux promoted by TFP and PROP could be attributed to a direct effect of these drugs over the platelet Ca2+ pump isoforms (Sarco Endoplasmic Reticulum Calcium ATPase, SERCA2b and SERCA3) themselves, as it was reported for the sarcoplasmic reticulum Ca2+ ATPase (SERCA1).


Asunto(s)
Plaquetas/metabolismo , ATPasas Transportadoras de Calcio/efectos de los fármacos , ATPasas Transportadoras de Calcio/metabolismo , Calcio/metabolismo , Propranolol/farmacología , Trifluoperazina/farmacología , Adenosina Trifosfato/metabolismo , Plaquetas/efectos de los fármacos , Calcimicina/farmacología , Señalización del Calcio/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Humanos , Técnicas In Vitro , Ionomicina/farmacología , Ionóforos/farmacología , Isoenzimas/efectos de los fármacos , Isoenzimas/metabolismo , Fosfatos/metabolismo , Rojo de Rutenio/farmacología , Espermidina/farmacología , Tapsigargina/farmacología
8.
J Neurosci Res ; 55(6): 776-81, 1999 Mar 15.
Artículo en Inglés | MEDLINE | ID: mdl-10220118

RESUMEN

Previous biochemical, autoradiographic, and ultrastructural data have shown that, in the synaptosomal fraction of the squid optic lobe, protein synthesis is largely due to the presynaptic terminals of the retinal photoreceptor neurons (Crispino et al. [1993a] Mol. Cell. Neurosci. 4:366-374; Crispino et al. [1993b] J. Neurochem. 61:1144-1146; Crispino et al. [1997] J. Neurosci. 17:7694-7702). We now report that this process is close to its maximum at the basal concentration of cytosolic Ca++, and is markedly inhibited when the concentration of this ion is either decreased or increased. This conclusion is supported by the results of experiments with: 1) compounds known to increase the level of cytosolic Ca++, such as A23187, ionomycin, thapsigargin, and caffeine; 2) compounds sequestering cytosolic calcium ions such as BAPTA-AM; and 3) agents that block the role of Ca++ as second messenger, such as TFP and W7, which inhibit calmodulin, and calphostin, which inhibits protein kinase C. We conclude that variations in the level of cytosolic Ca++ induced in presynaptic terminals by neuronal activity may contribute to the modulation of the local synthesis of protein.


Asunto(s)
Calcio/fisiología , Proteínas del Tejido Nervioso/biosíntesis , Terminales Presinápticos/metabolismo , Animales , Encéfalo/metabolismo , Cafeína/farmacología , Calcimicina/farmacología , Calcio/farmacología , Citosol/metabolismo , Decapodiformes , Ácido Egtácico/análogos & derivados , Ácido Egtácico/farmacología , Ionomicina/farmacología , Cinética , Magnesio/farmacología , Naftalenos/farmacología , Terminales Presinápticos/efectos de los fármacos , Sulfonamidas/farmacología , Sinaptosomas/efectos de los fármacos , Sinaptosomas/metabolismo , Tapsigargina/farmacología , Trifluoperazina/farmacología
9.
Neuroscience ; 90(2): 705-15, 1999 May.
Artículo en Inglés | MEDLINE | ID: mdl-10215172

RESUMEN

Ribosomes and polyribosomes were detected by immuno-electron microscopy in the giant axon and small axons of the squid using a polyclonal antibody against rat brain ribosomes. The ribosomal fraction used as antigen was purified by ultracentrifugation on a sucrose density gradient and shown to contain ribosomal RNAs and native ribosomes. The polyclonal antibody raised in rabbits reacted with at least ten proteins on immunoblots of purified rat brain ribosomes as well as with a set of multiple ribosomal proteins prepared from the squid giant fiber lobe. Immunoreactions were performed on cryostat sections of the stellate nerve cut at a distance of more than 3 cm from the stellate ganglion, using pre-embedding techniques. Ribosomes and polyribosomes were identified within the giant axon and small axons using electron microscopic methods, following binding of peroxidase-conjugated anti-rabbit IgG secondary antibody. Polysomes were more frequently localized in peripheral axoplasm, including the cortical layer of the giant axon, and were generally associated with unidentified cytoskeletal filaments or with dense matrix material. The immunochemical demonstration of ribosomes and polyribosomes in the giant axon and small axons of the squid confirms similar observations in the squid and the goldfish obtained with the method of electron spectroscopic imaging, and strongly supports the view that a local system of protein synthesis is present in axons. The immunochemical method here described offers an alternative tool for the selective identification of ribosomes, and is likely to prove of value in the analyses of other axonal systems.


Asunto(s)
Axones/ultraestructura , Polirribosomas/ultraestructura , Ribosomas/ultraestructura , Animales , Anticuerpos , Encéfalo/ultraestructura , Fraccionamiento Celular , Decapodiformes , Ganglios de Invertebrados/citología , Ganglios de Invertebrados/ultraestructura , Microscopía Inmunoelectrónica , Fibras Nerviosas/ultraestructura , Neuronas/ultraestructura , ARN Ribosómico/análisis , Conejos , Ratas , Proteínas Ribosómicas/análisis
10.
J Neurosci ; 17(20): 7694-702, 1997 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-9315891

RESUMEN

Previous data have suggested that the large nerve terminals present in the synaptosomal fraction from squid optic lobe are capable of protein synthesis (Crispino et al., 1993a,b). We have further examined this issue by comparing the translation products of synaptosomal and microsomal polysomes. Both preparations programmed an active process of translation, which was completely abolished by their previous treatment with EDTA. After immunoabsorption of the newly synthesized neurofilament (NF) proteins, the labeling ratio of the 60 and 70 kDa NF proteins was found to differ, in agreement with comparable differences obtained with intact synaptosomes. These observations indicate that the set of mRNAs translated by synaptosomes differs from that translated by nerve cell bodies. Hence, because NF proteins are neuron-specific, they support the view that the active synaptosomal polysomes are mostly localized in the large nerve terminals that represent the most abundant neuronal component of the fraction. This hypothesis was confirmed (1) by electron spectroscopic data demonstrating the presence of ribosomes and polysomes within the large nerve endings of the synaptosomal fraction, as well as in the carrot-like nerve endings of the retinal photoreceptors that constitute the only large terminals in the optic lobe, and (2) by light and high resolution autoradiography of synaptosomal samples incubated with [3H]leucine, showing that most labeled proteins are associated with the large nerve endings. This response was abolished by cycloheximide. Taken together, the data provide the first unequivocal demonstration that presynaptic nerve terminals are capable of protein synthesis.


Asunto(s)
Encéfalo/fisiología , Decapodiformes/fisiología , Polirribosomas/fisiología , Terminales Presinápticos/fisiología , Sinaptosomas/fisiología , Animales , Autorradiografía , Encéfalo/ultraestructura , Microscopía Electrónica , Microsomas/fisiología , Proteínas del Tejido Nervioso/metabolismo , Proteínas de Neurofilamentos/biosíntesis , Terminales Presinápticos/ultraestructura , Biosíntesis de Proteínas , Sinaptosomas/metabolismo , Sinaptosomas/ultraestructura
11.
Rev Epidemiol Sante Publique ; 45(6): 454-64, 1997 Dec.
Artículo en Francés | MEDLINE | ID: mdl-9496576

RESUMEN

BACKGROUND: The French health insurance has carried out a survey to estimate the medical and social prevalence for the 30 long-lasting affections. This estimation was extended to the instantaneous morbidity prevalence for some of these diseases. METHODS: The random sampling represented 2% of the 3,337,795 patients who were affected by long-lasting affections (ALD 30). To codify the diagnoses, the "médecin conseil" proceeded by different ways: either by examining the patient, by consulting the practicing physician (69% of the patients), or by consulting the individual medical file. Morbidity prevalence estimates were limited to some diseases: those for which correcting coefficients were available or those for which the legislation on long-lasting affections were applied in patients not likely to come under "invalidity". RESULTS: In November 1994, among the patients who came under "ALD 30", 39% were affected with cardio-vascular diseases, about 15% were affected with psychiatric diseases, and a similar proportion presented cancer or diabetes. The estimation of the insulin-dependent diabetes morbidity prevalence was 4.1/1000, non insulin-dependent diabetes 18/1000, progressive rheumatoid polyarthritis 2.8/1000, Parkinson disease 2.0/1000, and multiple sclerosis 0.4/1000. This survey also estimated the prevalence of seven other affections. CONCLUSIONS: This survey provides morbidity prevalence rates estimated on the basis of a representative sample of a sub-population including 70% of the French population. Most results are close to those which have been already published, but some of them appear quite new.


Asunto(s)
Enfermedad Crónica/epidemiología , Programas Nacionales de Salud , Adolescente , Adulto , Distribución por Edad , Anciano , Niño , Preescolar , Femenino , Francia/epidemiología , Humanos , Lactante , Masculino , Persona de Mediana Edad , Morbilidad , Vigilancia de la Población , Prevalencia , Distribución por Sexo , Encuestas y Cuestionarios
13.
Bull Cancer ; 82 Suppl 3: 230s-231s, 1995 Jul.
Artículo en Francés | MEDLINE | ID: mdl-7492837

RESUMEN

Faced with scientific progress, social security must be concerned by ethics, especially by protection of personal integrity. Financial necessities lead to take into account the efficiency of public health interventions. But in front of potentially toxic drug, are we allowed to compare possible advantages with potentially serious risks for healthy women? For these reasons, social security takes a stand in favour of carefully controlled trials, focused on restricted target populations which are estimated at high risk of cancer. Research of side effects should be included in the follow of the patients and special caution should be taken to avoid premature spreading of this behaviour. About a financial contribution of social security, the National fund for health prevention, education and information (FNPEIS) could perhaps not support such a project, regarding to his experimental nature. CNAMTS-INSERM research contracts could be an alternative.


Asunto(s)
Seguro de Salud/economía , Neoplasias/prevención & control , Prevención Primaria , Seguridad Social , Antineoplásicos/uso terapéutico , Ética Médica , Femenino , Francia , Humanos , Masculino , Neoplasias/tratamiento farmacológico , Neoplasias/economía , Defensa del Paciente , Factores de Riesgo
14.
Biochem J ; 306 ( Pt 1): 35-8, 1995 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-7864826

RESUMEN

In this study, the endoplasmic Ca2+ transport ATPase of blood platelets was compared with the Ca2+ ATPase of sarcoplasmic reticulum skeletal muscle. Similar to the muscle enzyme, the Ca2+ ATPase from platelets was found to catalyse an ATP<-->P(i) exchange both in the presence and in the absence of a transmembrane Ca2+ gradient. When platelet vesicles are loaded with Ca2+ and diluted in medium containing ADP, P(i) and EGTA, the ATPase catalyses Ca2+ efflux coupled to synthesis of ATP. The stoichiometry between Ca2+ ion released and ATP synthesized by platelet Ca2+ ATPase is 1, while that of skeletal muscle is 2. Thapsigargin, a specific inhibitor of sarcoplasmic/endoplasmic reticulum Ca2+ ATPases, inhibited both the Ca(2+)-dependent ATPase activity and the reversal of the platelet Ca2+ pump. The possibility is discussed that the differences observed between the two transport systems is related to the distinct amino acid sequences of the enzymes.


Asunto(s)
Plaquetas/metabolismo , Canales de Calcio/sangre , Adenosina Trifosfato/sangre , Calcimicina/farmacología , Calcio/sangre , ATPasas Transportadoras de Calcio/antagonistas & inhibidores , ATPasas Transportadoras de Calcio/sangre , Ácido Egtácico/farmacología , Humanos , Músculo Esquelético/enzimología , Retículo Sarcoplasmático/enzimología , Terpenos/farmacología , Tapsigargina
16.
Soc Sci Med ; 38(12): 1625-33, 1994 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-8047920

RESUMEN

From the failure of early voluntarist attempts of the 1970's to introduce formal economic assessment in administrative decision-making for public health policies, to the recent introduction of new regulatory mechanisms to control the diffusion and use of health care technologies, the French experience deeply questions the mechanistic idea that reinforcement of cost-containment policies necessarily means successful opportunities for economic appraisal. The article presents various examples from the French health care system showing how ambiguities between the management goals of cost-containment and the promotion of economic appraisal can create barriers for acceptance of any form of economic analysis. But, it also draws some positive lessons about the ways to surpass the traditional opposition between 'researcher-driven' vs 'policy-driven' research in the field of health economic assessment through institutional innovations and methodological advances.


Asunto(s)
Política de Salud/economía , Investigación sobre Servicios de Salud/economía , Evaluación de la Tecnología Biomédica/economía , Control de Costos , Análisis Costo-Beneficio , Toma de Decisiones en la Organización , Difusión de Innovaciones , Predicción , Francia , Política de Salud/tendencias , Investigación sobre Servicios de Salud/tendencias , Humanos , Objetivos Organizacionales , Evaluación de la Tecnología Biomédica/tendencias
18.
Biochem J ; 274 ( Pt 2): 427-32, 1991 Mar 01.
Artículo en Inglés | MEDLINE | ID: mdl-1826078

RESUMEN

Previously [Inesi & de Meis (1989) J. Biol. Chem. 264, 5929-5936] it was shown that dimethyl sulphoxide (Me2SO) increases the amount of Ca2+ accumulated by sarcoplasmic-reticulum vesicles. This effect was related to a decrease in the enzyme affinity for ADP from less than 20 microM to 1 mM. In the present work the apparent affinity of the ADP-sensitive phosphoenzyme for ADP was determined by measuring the rate of ATP synthesis in vesicles previously loaded with Ca2+, at different pH values and in the presence and absence of Me2SO (20%, v/v) and KCl. In all conditions tested, addition of Me2SO never promoted an increase of the apparent Km for ADP to a value higher than 25 microM. ADP inhibits the phosphorylation of the enzyme by Pi. Two components, with Ki values of 80 microM and 8 mM, were detected when vesicles previously loaded with Ca2+ were used. The high-affinity component (Ki 80 microM) was abolished after addition of Me2SO to the medium. Empty vesicles, on the other hand, exhibited only the low-affinity component (Ki 8 mM). During ATP synthesis in a totally aqueous medium, there was a decrease in the phosphoenzyme formed by Pi, after addition of 80-100 microM-ADP to the medium. In the presence of Me2SO this decrease was smaller. The sum of the fractions of phosphoenzyme formed by ATP and by Pi during Ca2+ uptake was higher in the presence of Me2SO than in a totally aqueous medium. Me2SO decreased the passive efflux of Ca2+ measured in the presence of 0.1 mM-Pi and 0.1 mM-MgCl2. In a totally aqueous medium the same decrease was observed when Pi and MgCl2 concentrations were raised to 4 mM. These data suggest that ADP binds to two different enzyme conformations. The binding to one of these conformations (*E) inhibits the phosphorylation of the enzyme by Pi, increases the efflux of Ca2+ and decreases the amount of Ca2+ accumulated by the vesicles.


Asunto(s)
Adenosina Trifosfatasas/metabolismo , Calcio/metabolismo , Retículo Sarcoplasmático/metabolismo , Adenosina Trifosfato/metabolismo , Animales , Dimetilsulfóxido/farmacología , Cinética , Músculos/metabolismo , Fosfatos/metabolismo , Radioisótopos de Fósforo , Fosforilación , Conejos , Retículo Sarcoplasmático/efectos de los fármacos
19.
Rev Epidemiol Sante Publique ; 39(4): 353-64, 1991.
Artículo en Francés | MEDLINE | ID: mdl-1754701

RESUMEN

The authors have studied the cost of the different treatments proposed in ESRD to patients attended by the same nephrologic team. For each patient they have isolated two consecutive periods of treatment, each six months apart. Treatment modifications noted between the two periods allowed the patient to be used as his own control. The results show that the costs are essentially composed of the dialysis sessions, hospitalisations and transport, and that their level and composition differ significantly between the different treatments. They derive a typology composed of three groups of patients, which differ in their treatment, age, duration of ESRD, complications, and total cost of treatment. They conclude that services should be organised in such a way that a range of different treatments can reasonably be provided, according to patient needs.


Asunto(s)
Seguro de Salud/economía , Fallo Renal Crónico/economía , Diálisis Renal/economía , Adulto , Costos y Análisis de Costo , Europa (Continente) , Francia , Hospitalización/economía , Humanos , Fallo Renal Crónico/terapia , Persona de Mediana Edad , Diálisis Peritoneal Ambulatoria Continua/economía , Transportes/economía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...